ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2021
Symptoms of major depressive disorder during the COVID-19 pandemic: results from a representative sample of the Canadian population.
Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Evaluating the Efficacy of Telehealth-Based Treatments for Depression in Adults: A Rapid Review and Meta-Analysis.Journal of occupational rehabilitation · 2025Pooled it
- Article
- Risk stratification and healthcare disparities in COVID-19 outcomes: a retrospective cohort study of treatment pathways before and after infection.BMC infectious diseases · 2025Article
- Prevalence and correlates of severe depressive symptoms among Arab, Asian, Black, Indigenous, White, and mixed-race individuals in Canada: a population-based study.Lancet regional health. Americas · 2025Article
- Sex-specific estimates of positive mental health among youth before and during the COVID-19 pandemic in Canada.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025Article
- Impact of the Covid-19 pandemic on mental health of persons with disabilities: Insights from the 2021 Canadian Housing Survey.PLOS global public health · 2025Article
- Predictors of depression trajectories during the COVID-19 pandemic in adults with rheumatoid arthritis: results from the Canadian Early Arthritis Cohort.Rheumatology advances in practice · 2025Article
- Major depressive disorders in children aged 5-14 years: a Global Burden of Disease analysis from the perspective of exercise psychology.Frontiers in public health · 2025Article
- Digital health monitoring for adults with treatment-resistant depression: Observational feasibility study protocol.PloS one · 2025Article
- Psychological well-being and its associations with sociodemographic characteristics, physical health, substance use and other mental health outcomes among adults in Canada.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024Article
- Assessing the impact of COVID-19 on self-reported levels of depression during the pandemic relative to pre-pandemic among Canadian adults.Archives of public health = Archives belges de sante publique · 2024Article
- Associations between negative COVID-19 experiences and symptoms of anxiety and depression: a study based on a representative Canadian national sample.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2024Article
- Walk-in mental health: Bridging barriers in a pandemic.PloS one · 2024Article
- A narrative review: suicide and suicidal behaviour in older adults.Frontiers in psychiatry · 2024Review
- Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report.The mental health clinician · 2023Article
- Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study.Journal of clinical medicine · 2023Article
- Depression, parenting and the COVID-19 pandemic in Canada: results from three nationally representative cross-sectional surveys.BMJ open · 2023Article
- Associations of sleep duration and sleep quality with indicators of mental health among youth and adults: findings from the 2015 Canadian Community Health Survey.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2023Article
- Social isolation, loneliness and positive mental health among older adults in Canada during the COVID-19 pandemic.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2023Article
- Pandemic-related impacts and suicidal ideation among adults in Canada: a population-based cross-sectional study.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSince the outbreak of COVID-19, numerous studies from around the world have reported declines in mental health. However, most of these studies were of low-to-moderate quality and many were based on convenience samples or used mental health measures with low validity, or both. Consequently, it has been difficult to draw conclusions.
methodsBoth the 2020 Survey on COVID-19 and Mental Health (SCMH) and the Canadian Community Health Survey (CCHS) (2015-2019) used the Patient Health Questionnaire-9 to screen for major depressive disorder (MDD) in adults aged 18 or older. The prevalence of MDD was compared between the SCMH and the CCHS. Risk and protective factors for MDD in the SCMH were examined using bivariate and logistic regression analyses.
resultsBased on SCMH data, 15.2% (95% CI: 14.2-16.2) of Canadians screened positive for MDD. The prevalence of MDD was more than two times higher in the SCMH (during COVID-19) than in the CCHS (predating COVID-19). In bivariate analysis, Canadians reporting five or more COVID-19-related risk factors were close to 30 times more likely to have MDD than those reporting no risk factors. Mastery and a sense of community belonging were protective factors for MDD.
conclusionAfter remaining stable for two decades, the prevalence of depression among Canadians increased substantially with the onset of COVID-19. Ongoing monitoring of this common condition associated with major morbidity is vital to determine if elevated levels of MDD persist as we progress through and beyond future waves of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.